J Hallberg1,2, P Thunqvist1,2,3, E S Schultz1, I Kull1,2,3, M Bottai1, A-S Merritt1,4, F Chiesa5, P M Gustafsson6,7, E Melén1,2,8. 1. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. 2. Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden. 3. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden. 4. Centre for occupational and environmental medicine, Stockholm County Council, Stockholm, Sweden. 5. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 6. The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. 7. Department of Pediatrics, Central Hospital, Skövde, Sweden. 8. Centre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Asthma is a disease affecting many locations throughout the airway. Most studies have used spirometry as the primary assessment of airway obstruction, a method that may be less sensitive in regard to peripheral airway obstruction. The aim of this study was to elucidate the associations between asthma phenotypes based on age of onset and duration of symptoms, and (i) spirometry and (ii) small airway involvement measured by impulse oscillometry (IOS) in adolescence. METHODS: Children and adolescents taking part in BAMSE, a prospective birth cohort study, performed spirometry at 8 and 16 years and IOS at 16 years of age. Based on data collected in questionnaires, children were categorized into the following groups: 'never asthma', 'early transient asthma', 'early persistent asthma', and 'late onset asthma'. RESULTS: Compared with the never asthma group, all asthma groups were associated with lower FEV1 at 16 years of age (early transient-119 ml, 95% confidence interval -204 to -34; early persistent-410 ml, 95%CI -533; -287; and late onset-148 ml, 95%CI -237; -58). Between 8 and 16 years, significantly less increase in FEV1 was observed in the early persistent and late onset groups. The small airway index 'R5-20 ' was significantly associated with active asthma at 16 years, but not transient asthma. CONCLUSIONS: All asthma phenotypes studied were negatively associated with FEV1 in adolescence. IOS measurements indicated that active asthma could be associated with small airway impairments. These results provide new insights into the physiology underlying wheezing phenotypes based on age of onset and duration of disease.
BACKGROUND:Asthma is a disease affecting many locations throughout the airway. Most studies have used spirometry as the primary assessment of airway obstruction, a method that may be less sensitive in regard to peripheral airway obstruction. The aim of this study was to elucidate the associations between asthma phenotypes based on age of onset and duration of symptoms, and (i) spirometry and (ii) small airway involvement measured by impulse oscillometry (IOS) in adolescence. METHODS:Children and adolescents taking part in BAMSE, a prospective birth cohort study, performed spirometry at 8 and 16 years and IOS at 16 years of age. Based on data collected in questionnaires, children were categorized into the following groups: 'never asthma', 'early transient asthma', 'early persistent asthma', and 'late onset asthma'. RESULTS: Compared with the never asthma group, all asthma groups were associated with lower FEV1 at 16 years of age (early transient-119 ml, 95% confidence interval -204 to -34; early persistent-410 ml, 95%CI -533; -287; and late onset-148 ml, 95%CI -237; -58). Between 8 and 16 years, significantly less increase in FEV1 was observed in the early persistent and late onset groups. The small airway index 'R5-20 ' was significantly associated with active asthma at 16 years, but not transient asthma. CONCLUSIONS: All asthma phenotypes studied were negatively associated with FEV1 in adolescence. IOS measurements indicated that active asthma could be associated with small airway impairments. These results provide new insights into the physiology underlying wheezing phenotypes based on age of onset and duration of disease.
Authors: Ida Mogensen; Jenny Hallberg; Lena Palmberg; Sandra Ekström; Antonios Georgelis; Erik Melén; Anna Bergström; Inger Kull Journal: ERJ Open Res Date: 2022-06-20
Authors: Nandini Mukherjee; Gabrielle A Lockett; Simon K Merid; Erik Melén; Göran Pershagen; John W Holloway; Syed Hasan Arshad; Susan Ewart; Hongmei Zhang; Wilfried Karmaus Journal: Int J Mol Epidemiol Genet Date: 2016-03-23
Authors: Petra Um-Bergström; Jenny Hallberg; Per Thunqvist; Eva Berggren-Broström; Martin Anderson; Gunilla Adenfelt; Gunnar Lilja; Giovanni Ferrara; C Magnus Sköld; Erik Melén Journal: BMC Pulm Med Date: 2017-06-30 Impact factor: 3.317
Authors: Anna Bergström; Erik Melén; Sandra Ekström; Jenny Hallberg; Inger Kull; Jennifer L P Protudjer; Per Thunqvist; Matteo Bottai; Per Magnus Gustafsson Journal: Thorax Date: 2018-01-29 Impact factor: 9.139
Authors: Jesse D Thacher; Erica S Schultz; Jenny Hallberg; Ulrika Hellberg; Inger Kull; Per Thunqvist; Göran Pershagen; Per M Gustafsson; Erik Melén; Anna Bergström Journal: Eur Respir J Date: 2018-06-07 Impact factor: 16.671